After a thorough report, these analysts have shortlisted some stocks for you, which can be a game-changer for your portfolio.
1. Buy Zydus Lifesciences: KR Choksey
- Zydus Lifesciences, a pharmaceutical company, has a growth rate of 9.4% as compared to Maket’s overall growth of 9.5% because of strong sales in cardiac and anti-infective medicines. Still, they have poor sales growth in respiratory medicines.
- 33% of their revenue comes from two major products, Glucon-D and Nycil.
- Zydus Lifescience’s new drug, Zituvio, was approved in the US, and its sales will boost in the coming years.
- Revlimid, a medicine, can expect a boost in sales soon.
- The company is also planning to buy back its shares.
- The new target for these shares is Rs. 1006 per share. The company’s stock price is expected to grow 17.3% from its current price.
2. Buy Nippon Life India Asset Management: Prabhudas Lilladher
- NAM is performing well in equity investments, leading to increased market share and investor interest. The company also focuses on managing its risk and investing process carefully The company also has a strong presence in the retail market, and growth can be seen in SIP and AUM.
- NAM is the 4th largest player in the market, with a market share of 7.7%. The Indian mutual fund industry has room to grow, and the company can benefit from it.
- A CAGR of 23.4% can be expected from the company between FY 24 and FY 26.
- Prabhudas Lilladher sets a target of Rs. 610 per share.
3. Buy Mahanagar Gas Ltd.: Motilal Oswal
- MAHGL stock price declined by 15% on March 6, 2024, due to statements made by the petroleum and natural gas minister. He said that the benefits of gas sector reforms haven’t exactly reached customers, and city gas distribution (CGD) companies are making a significant profit. The fall in stock price could be led by the minister’s statement that CGD is earning higher profits.
- Stock’s current decline is due to an overreaction to the minister’s comments, and partly another reason is investors booking profit due to a significant increase in six months.
- The company has strong growth potential, but the current price does not justify its potential, so one can expect it to grow. MAHGL has solid growth prospects with consistent volume growth.
- The target of Rs. 1665 per share is set by Motilal Oswal.
4. Buy HDFC Bank: LKP Research
- The stock price of HDFC has been on a declining trend for the past 3 years, especially in the last 6 months. Its performance has been in complete decline.
- The company’s operating expenses are high; they constitute about 40% of their earnings. Returns from their investments are decreasing because of the higher loan exposure of HDFC Ltd.; the bank’s profitability has decreased by 2% in the third quarter of FY24.
- P/BVPS is a common metric to assess a bank’s value. HDFC’s price-to-book per share value is 2.78, which is comparatively less than its 5-year peak of 5.8, which indicates that the stock is relatively cheaper now. The current average is lower than its historical average of 3.8.
- The target of Rs. 1762 per share is set by LKP research, which recommends it as a strong buy.
Disclaimer: The views and recommendations made above are those of individual analysts or brokerage companies and not of TheStockMarketLive. We advise investors to check with certified experts before making any investment decisions.
